NCT06125405View on ClinicalTrials.gov

Study of the Telitacicept in Pediatric Patients With Frequently Relapsing or Steroid Dependent Nephrotic Syndrome

PHASE3RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 28, 2023

Primary Completion Date

October 24, 2026

Study Completion Date

October 24, 2027

Conditions
Nephrotic Syndrome in ChildrenTelitacicept
Interventions
DRUG

Telitacicept

The study duration was 52 weeks, with the experimental group receiving subcutaneous injections of Telitacicept once weekly for a total of 52 weeks.

Trial Locations (1)

Unknown

RECRUITING

Children's Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

The Children's Hospital of Zhejiang University School of Medicine

OTHER